Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Therapeutic Discovery

IGF-1R/MDM2 Relationship Confers Enhanced Sensitivity to RITA in Ewing Sarcoma Cells

Giusy Di Conza, Marianna Buttarelli, Olimpia Monti, Marsha Pellegrino, Francesca Mancini, Alfredo Pontecorvi, Katia Scotlandi and Fabiola Moretti
Giusy Di Conza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianna Buttarelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olimpia Monti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marsha Pellegrino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Mancini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfredo Pontecorvi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katia Scotlandi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiola Moretti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-11-0913 Published June 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2012 to January 2021

AbstractFull-text HTMLPDF
Total290419401589

Cited By

Article Information

Volume 11, Issue 6, pp. 1247-1256

DOI 
https://doi.org/10.1158/1535-7163.MCT-11-0913
PubMed 
22461661

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received November 9, 2011
  • Revision received February 13, 2012
  • Accepted March 5, 2012
  • Published first March 28, 2012.

Article Versions

  • Previous version (March 28, 2012 - 13:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. Giusy Di Conza1,4,
  2. Marianna Buttarelli1,2,
  3. Olimpia Monti1,
  4. Marsha Pellegrino1,3,
  5. Francesca Mancini1,3,
  6. Alfredo Pontecorvi3,
  7. Katia Scotlandi5, and
  8. Fabiola Moretti1
  1. Authors' Affiliations: 1Cell Biology and Neurobiology Institute-CNR/Fondazione Santa Lucia; 2Department of Surgery, Breast Unit; 3Division of Endocrinology, Catholic University of Rome, Rome; 4Department of Experimental-Clinical Medicine and Pharmacology, University of Messina, Messina; and 5CRS Development of Biomolecular Therapies, Lab Experimental Oncology, Orthopaedic Rizzoli Institute, Bologna, Italy
  1. Corresponding Author:
    Fabiola Moretti, Cell Biology and Neurobiology Institute-CNR/Fondazione Santa Lucia, Via del Fosso di Fiorano 64, 00143. Phone: 39-06-501-703-242; Fax: 39-06-501-703-313; E-mail: fabiola.moretti{at}cnr.it; or Katia Scotlandi, E-mail: katia.scotlandi{at}ior.it
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 11 (6)
June 2012
Volume 11, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IGF-1R/MDM2 Relationship Confers Enhanced Sensitivity to RITA in Ewing Sarcoma Cells
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
IGF-1R/MDM2 Relationship Confers Enhanced Sensitivity to RITA in Ewing Sarcoma Cells
Giusy Di Conza, Marianna Buttarelli, Olimpia Monti, Marsha Pellegrino, Francesca Mancini, Alfredo Pontecorvi, Katia Scotlandi and Fabiola Moretti
Mol Cancer Ther June 1 2012 (11) (6) 1247-1256; DOI: 10.1158/1535-7163.MCT-11-0913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
IGF-1R/MDM2 Relationship Confers Enhanced Sensitivity to RITA in Ewing Sarcoma Cells
Giusy Di Conza, Marianna Buttarelli, Olimpia Monti, Marsha Pellegrino, Francesca Mancini, Alfredo Pontecorvi, Katia Scotlandi and Fabiola Moretti
Mol Cancer Ther June 1 2012 (11) (6) 1247-1256; DOI: 10.1158/1535-7163.MCT-11-0913
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Sorafenib Targets VCP in Hepatocellular Cancer Cells
  • RSK2 as Therapeutic Target for Myeloma
  • Dll4-Fc Suppresses Liver Metastasis of SCLC Cells
Show more Therapeutic Discovery
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement